Edition:
United States

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

2.46USD
20 Nov 2018
Change (% chg)

-- (--)
Prev Close
$2.46
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
132,112
52-wk High
$5.10
52-wk Low
$2.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.18 December 21 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 4 4 4
(3) HOLD 1 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3 5.67 7.40 4.24 8.85
Quarter Ending Mar-19 3 5.90 7.24 4.74 --
Year Ending Dec-18 3 16.59 18.30 15.17 32.04
Year Ending Dec-19 3 29.18 34.76 24.08 69.95
Earnings (per share)
Quarter Ending Dec-18 3 -0.18 -0.16 -0.22 -0.09
Quarter Ending Mar-19 2 -0.17 -0.13 -0.20 --
Year Ending Dec-18 3 -0.89 -0.86 -0.93 -0.35
Year Ending Dec-19 3 -0.55 -0.43 -0.69 0.47

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 5.23 3.83 1.39 26.65
Quarter Ending Jun-18 3.98 3.92 0.06 1.57
Quarter Ending Mar-18 3.58 3.18 0.40 11.08
Quarter Ending Dec-17 4.11 2.84 1.27 30.82
Quarter Ending Sep-17 4.40 3.39 1.01 22.97

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5.67 8.95 9.17 9.17 8.85
Quarter Ending Mar-19 5.90 6.77 7.78 7.78 --
Year Ending Dec-18 16.59 21.13 21.50 21.47 32.04
Year Ending Dec-19 29.18 35.28 36.13 36.01 69.95

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 2 0 3
Quarter Ending Mar-19 1 0 1 0
Year Ending Dec-18 0 2 0 3
Year Ending Dec-19 1 1 1 2
Earnings